Algernon Pharmaceuticals Inc (AGN.CX)
0.115
+0.01
(+9.52%)
CAD |
CNSX |
May 01, 16:00
Algernon Pharmaceuticals Max Drawdown (5Y): 99.52% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 99.52% |
| March 31, 2024 | 99.52% |
| February 29, 2024 | 99.52% |
| January 31, 2024 | 99.52% |
| December 31, 2023 | 99.52% |
| November 30, 2023 | 99.52% |
| October 31, 2023 | 99.44% |
| September 30, 2023 | 98.88% |
| August 31, 2023 | 98.68% |
| July 31, 2023 | 98.56% |
| June 30, 2023 | 98.56% |
| May 31, 2023 | 98.36% |
| April 30, 2023 | 98.12% |
| March 31, 2023 | 97.80% |
| February 28, 2023 | 97.36% |
| January 31, 2023 | 97.36% |
| December 31, 2022 | 97.36% |
| November 30, 2022 | 97.36% |
| October 31, 2022 | 97.36% |
| September 30, 2022 | 96.57% |
| August 31, 2022 | 96.57% |
| July 31, 2022 | 96.57% |
| June 30, 2022 | 96.30% |
| May 31, 2022 | 96.30% |
| April 30, 2022 | 96.30% |
| Date | Value |
|---|---|
| March 31, 2022 | 96.30% |
| February 28, 2022 | 96.30% |
| January 31, 2022 | 96.30% |
| December 31, 2021 | 96.30% |
| November 30, 2021 | 96.30% |
| October 31, 2021 | 96.30% |
| September 30, 2021 | 96.30% |
| August 31, 2021 | 96.30% |
| July 31, 2021 | 96.30% |
| June 30, 2021 | 96.30% |
| May 31, 2021 | 96.30% |
| April 30, 2021 | 96.30% |
| March 31, 2021 | 96.30% |
| February 28, 2021 | 96.30% |
| January 31, 2021 | 96.30% |
| December 31, 2020 | 96.30% |
| November 30, 2020 | 96.30% |
| October 31, 2020 | 96.30% |
| September 30, 2020 | 96.30% |
| August 31, 2020 | 96.30% |
| July 31, 2020 | 96.30% |
| June 30, 2020 | 96.30% |
| May 31, 2020 | 96.30% |
| April 30, 2020 | 96.30% |
| March 31, 2020 | 96.30% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
89.35%
Minimum
May 2019
99.52%
Maximum
Nov 2023
96.40%
Average
96.30%
Median
Nov 2019
Max Drawdown (5Y) Benchmarks
| Biocure Technology Inc | 99.70% |
| Core One Labs Inc | 99.78% |
| Nova Mentis Life Science Corp | 99.28% |
| Nanosphere Health Sciences Inc | 99.95% |
| Lobe Sciences Ltd | -- |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -54.34 |
| Beta (5Y) | -0.5338 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 129.3% |
| Historical Sharpe Ratio (5Y) | -0.4489 |
| Historical Sortino (5Y) | -1.170 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 43.89% |